Fund Holdings — Deep Track Capital, LP

Total Portfolio Value:
$3.13B
Total Bought:
$552.55M
Total Sold:
$882.94M
Net Transaction:
-$330.39M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
argenx SEADR(ARGX)400,000365,000-35,000$172.02M$197.86M6.32%+$25.84M
Dynavax Technologies Corp10,900,00012,526,486+1,626,486$122.41M$139.55M4.46%+$17.14M
Guardant Health, Inc.(GH)4,500,0006,000,560+1,500,560$129.96M$137.65M4.39%+$7.69M
Apellis Pharmaceuticals Inc
COM
2,500,0004,400,654+1,900,654$95.90M$126.91M4.05%+$31.01M
Immunovant, Inc.(IMVT)2,883,7364,347,464+1,463,728$76.13M$123.95M3.96%+$47.82M
Springworks Therapeutics Inc3,700,0003,843,900+143,900$139.38M$123.16M3.93%-$16.22M
Dyne Therapeutics, Inc.(DYN)4,000,0003,282,000-718,000$141.16M$117.89M3.76%-$23.27M
Intra-Cellular Therapies Inc1,537,9221,600,693+62,771$105.33M$117.12M3.74%+$11.79M
Ocular Therapeutix, Inc.(OCUL)12,721,46012,721,4600$87.01M$110.68M3.53%+$23.66M
Intellia Therapeutics, Inc.(NTLA)4,800,0004,950,000+150,000$107.42M$101.72M3.25%-$5.70M
Alkermes plcSHS(ALKS)3,500,0003,500,0000$84.35M$97.97M3.13%+$13.62M
Verona Pharma PlcADS4,000,0003,180,025-819,975$57.84M$91.49M2.92%+$33.65M
Ionis Pharmaceuticals, Inc.(IONS)2,000,0002,200,000+200,000$95.32M$88.13M2.81%-$7.19M
Nurix Therapeutics, Inc.(NRIX)3,991,5003,868,104-123,396$83.30M$86.92M2.77%+$3.61M
Viridian Therapeutics, Inc.(VRDN)3,923,8493,750,945-172,904$51.05M$85.33M2.72%+$34.28M
Bicycle Therapeutics PlcADS3,490,5063,548,001+57,495$70.65M$80.29M2.56%+$9.64M
MBX Biosciences, Inc.(MBX)03,018,935+3,018,935$0$78.43M2.50%+$78.43M
Axsome Therapeutics, Inc.(AXSM)1,852,784857,219-995,565$149.15M$77.04M2.46%-$72.11M
Pliant Therapeutics, Inc.(PLRX)5,972,2575,972,2570$64.20M$66.95M2.14%+$2.75M
Apogee Therapeutics Inc1,000,0001,000,0000$39.35M$58.74M1.88%+$19.39M
Autolus Therapeutics plcADS(AUTL)15,272,17215,272,1720$53.15M$55.44M1.77%+$2.29M
Structure Therapeutics IncADS950,0001,220,508+270,508$37.31M$53.57M1.71%+$16.26M
Olema Pharmaceuticals, Inc.(OLMA)4,000,0004,000,0000$43.28M$47.76M1.52%+$4.48M
Terns Pharmaceuticals Inc6,100,0005,576,558-523,442$41.54M$46.51M1.48%+$4.97M
4d Molecular Therapeutics In4,061,4014,096,452+35,051$85.25M$44.28M1.41%-$40.97M
ABIVAX Société AnonymeADS(ABVX)4,179,7633,579,209-600,554$55.26M$41.23M1.32%-$14.02M
TG Therapeutics, Inc.(TGTX)2,870,1311,725,000-1,145,131$51.06M$40.35M1.29%-$10.71M
Mind Medicine Mindmed Inc6,103,8177,065,099+961,282$44.01M$40.20M1.28%-$3.81M
Kura Oncology, Inc.(KURA)384,7561,963,505+1,578,749$7.92M$38.37M1.22%+$30.44M
Geron Corporation(GERN)13,000,0007,575,049-5,424,951$55.12M$34.39M1.10%-$20.73M
Cytokinetics, Incorporated(CYTK)132,495629,906+497,411$7.18M$33.26M1.06%+$26.08M
Oruka Therapeutics, Inc.(ORKA)01,235,187+1,235,187$0$30.27M0.97%+$30.27M
ANI Pharmaceuticals, Inc.(ANIP)466,089504,828+38,739$29.68M$30.12M0.96%+$437.5K
Spyre Therapeutics, Inc.(SYRE)1,756,6671,000,000-756,667$41.30M$29.41M0.94%-$11.89M
Edgewise Therapeutics, Inc.(EWTX)186,3861,100,536+914,150$3.36M$29.37M0.94%+$26.02M
Kymera Therapeutics, Inc.(KYMR)1,500,000600,326-899,674$44.77M$28.41M0.91%-$16.36M
Korro Bio, Inc.(KRRO)770,645850,000+79,355$26.10M$28.41M0.91%+$2.31M
Avidity Biosciences Inc0475,000+475,000$0$21.82M0.70%+$21.82M
Centessa Pharmaceuticals PlcADS01,350,000+1,350,000$0$21.59M0.69%+$21.59M
Alector Inc4,631,9984,631,9980$21.03M$21.59M0.69%+$555.8K
Nektar Therapeutics(NKTR)17,875,49815,922,655-1,952,843$22.17M$20.70M0.66%-$1.47M
89bio Inc2,294,0112,766,512+472,501$18.38M$20.47M0.65%+$2.10M
Bicara Therapeutics Inc0796,852+796,852$0$20.30M0.65%+$20.30M
Akero Therapeutics Inc0689,784+689,784$0$19.79M0.63%+$19.79M
Fate Therapeutics, Inc.(FATE)5,572,6075,572,6070$18.28M$19.50M0.62%+$1.23M
Silence Therapeutics plcADS(SLN)1,359,7451,000,000-359,745$25.84M$18.18M0.58%-$7.66M
Engene Holdings Inc
COM
2,250,0002,607,633+357,633$21.22M$17.21M0.55%-$4.01M
Editas Medicine, Inc.(EDIT)6,000,0004,900,334-1,099,666$28.02M$16.71M0.53%-$11.31M
Xencor, Inc.(XNCR)0800,000+800,000$0$16.09M0.51%+$16.09M
Pyxis Oncology, Inc.(PYXS)4,184,1004,184,1000$13.85M$15.36M0.49%+$1.51M
Context Therapeutics Inc.(CNTX)7,419,3557,419,3550$14.88M$14.54M0.46%-$333.9K
Cybin D/B/A Helus Pharma(HELP)01,529,987+1,529,987$0$13.60M0.43%+$13.60M
Zura Bio LimitedCL A(ZURA)3,283,7833,283,7830$11.49M$13.33M0.43%+$1.84M
Invivyd, Inc.(IVVD)10,953,93710,953,9370$12.05M$11.17M0.36%-$876.3K
Climb Bio, Inc.(CLYM)3,904,7852,169,143-1,735,642$27.76M$11.04M0.35%-$16.72M
Inovio Pharmaceuticals, Inc.(INO)2,066,7201,804,366-262,354$16.70M$10.43M0.33%-$6.27M
Avalo Therapeutics, Inc.(AVTX)0967,000+967,000$0$9.19M0.29%+$9.19M
Neumora Therapeutics, Inc.(NMRA)0567,428+567,428$0$7.50M0.24%+$7.50M
Travere Therapeutics, Inc.(TVTX)7,370,000531,857-6,838,143$60.58M$7.44M0.24%-$53.14M
Vigil Neuroscience Inc597,2151,553,996+956,781$2.39M$5.28M0.17%+$2.89M
Regulus Therapeutics Inc3,262,5643,262,5640$5.82M$5.12M0.16%-$701.5K
Allakos Inc5,000,0005,000,0000$5.00M$3.27M0.10%-$1.73M
Alto Neuroscience, Inc.(ANRO)511,686219,648-292,038$5.47M$2.51M0.08%-$2.96M
Prothena Corp PlcSHS
SHS
0140,000+140,000$0$2.34M0.07%+$2.34M
Relmada Therapeutics, Inc.(RLMD)1,234,773674,833-559,940$3.70M$2.19M0.07%-$1.52M
Aligos Therapeutics, Inc.(ALGS)0244,110+244,110$0$2.11M0.07%+$2.11M
Syros Pharmaceuticals Inc828,485828,4850$4.27M$1.78M0.06%-$2.49M
Metagenomi Therapeutics, Inc.(MGX)466,232307,500-158,732$1.90M$667.3K0.02%-$1.23M
Scholar Rock Holding Corporation(SRRK)372,55948,100-324,459$3.10M$385.3K0.01%-$2.72M
Agenus Inc.(AGEN)313,3590-313,359$5.25M$0—-$5.25M
Aligos Therapeutics Inc6,102,7700-6,102,770$2.14M$0—-$2.14M
Alnylam Pharmaceuticals, Inc.(ALNY)500,0000-500,000$121.50M$0—-$121.50M
Amgen Inc.(AMGN)575,0000-575,000$179.66M$0—-$179.66M
Cogent Biosciences, Inc.(COGT)308,2350-308,235$2.60M$0—-$2.60M
Cybin D/B/A Helus Pharma(HELP)58,139,5350-58,139,535$15.76M$0—-$15.76M
Hillevax Inc1,832,6520-1,832,652$26.50M$0—-$26.50M
Insmed Incorporated(INSM)2,000,0000-2,000,000$134.00M$0—-$134.00M
Praxis Precision Medicines, Inc.(PRAX)389,5460-389,546$16.11M$0—-$16.11M
Repare Therapeutics Inc904,2610-904,261$2.98M$0—-$2.98M
Page 1 of 1
Deep Track Capital, LP — 13F Holdings — Q3 2024 | TickerTrail